RKLB - Rocket Lab USA

Don't buy it here; fell 50-60% and nobody's buying; big supply; like an egg splat; maybe long-term but not tradable now.

Number two American launch company with dedicated small launches; record Q2 revenue up 62%, backlog up 137%, and Iridium acquisition adds recurring revenue.

Rocket Lab is the number two American launch company, with record Q2 revenue of $234M up 62% and backlog up 137%. It is well positioned for dedicated small launches and satellite manufacturing, and is acquiring Iridium to expand recurring revenue.

Matt's largest position. He believes the stock was overvalued at $151 but is attractive at $72, citing vertical integration, defense contracts, and Iridium Communications' cash flow.

Listed as a zombie stock: burning cash and unable to cover interest payments; high dilution risk.

Host doesn't follow Rocket Lab closely and says he would actually be closer to buying SpaceX, but acknowledges it as a pure-play space name.

Never should have reached $80B market cap on $662M TTM revenue and barely expected profitability; valuation excessive.

Guest did due diligence and missed the entry. If SpaceX continues to fall and pulls down space names, Rocket Lab would be his likely pick as 'the real second place.' Host prefers market leaders (SpaceX) over second-place names.

Pullback from long-term uptrend provides buying opportunity, strong growth potential in space industry.

Pullback to previous breakout area after a 50% move. Good risk/reward if buying near support with stop below. Not perfect pattern but favorable.